Pharmacotherapy for anxiety disorders in children and adolescents: An evidence-based medicine review

Scott N. Compton, Christopher J. Kratochvil, John S. March

Research output: Contribution to journalReview article

5 Scopus citations

Abstract

These studies generally support the use of the SSRIs fluvoxamine, sertraline, and fluoxetine in the acute treatment of pediatric non-OCD anxiety disorders. Two large multicenter studies suggest a favorable outcome for paroxetine in the treatment of pediatric social anxiety disorder. Mixed results currently exist for the use of extended-release venlafaxine in the treatment of pediatric generalized anxiety disorder. In both of these latter studies, concerns with safety were present.

Original languageEnglish (US)
Pages (from-to)504-517
Number of pages14
JournalPsychiatric Annals
Volume37
Issue number7
DOIs
StatePublished - Jul 2007

ASJC Scopus subject areas

  • Psychiatry and Mental health

Fingerprint Dive into the research topics of 'Pharmacotherapy for anxiety disorders in children and adolescents: An evidence-based medicine review'. Together they form a unique fingerprint.

  • Cite this